News for 'FDA'

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Shuks leads pivotal muscle-loss study aboard ISS

Shuks leads pivotal muscle-loss study aboard ISS

Rediff.com1 Jul 2025

Group Captain Shubhanshu Shukla, the first Indian astronaut at the International Space Station (ISS), conducted a critical biomedical experiment aboard the ISS on flight day 6 of the Axiom 4 Mission, focusing on how microgravity contributes to muscle loss.

Sena MLA booked for slapping canteen worker, threatens MIM leader

Sena MLA booked for slapping canteen worker, threatens MIM leader

Rediff.com12 Jul 2025

A non-cognisable offence is being filed against Shiv Sena MLA Sanjay Gaikwad in connection with the assault of a canteen worker at the MLA hostel. The incident sparked outrage after a video surfaced showing Gaikwad assaulting the worker over allegedly stale food.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Sena MLA slaps canteen staff over stale food, says no regret

Sena MLA slaps canteen staff over stale food, says no regret

Rediff.com10 Jul 2025

Ruling Shiv Sena's MLA Sanjay Gaikwad allegedly slapped an employee of a canteen at the MLA's hostel in Mumbai after complaining about being served stale food.

Fadnavis, Shinde condemn Sena MLA's assault on canteen staffer

Fadnavis, Shinde condemn Sena MLA's assault on canteen staffer

Rediff.com9 Jul 2025

Maharashtra Chief Minister Devendra Fadnavis on Wednesday said the incident of Shiv Sena MLA Sanjay Gaikwad slapping an employee of a canteen at the MLAs' hostel in Mumbai sends out a wrong message about all legislators that they indulge in misuse of power.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com5 Jun 2025

'We recently launched Yesintek in the immunology space.'

Who Is Gauri Spratt, Aamir's Latest Love?

Who Is Gauri Spratt, Aamir's Latest Love?

Rediff.com14 Mar 2025

Her grandfather Philip Spratt was accused by the British Raj in the Meerut Conspiracy Case in the late 1920s. Meet the lady in Aamir Khan's life.

US FDA warns against side effects of malaria drug

US FDA warns against side effects of malaria drug

Rediff.com25 Apr 2020

FDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile to be distributed.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Indian-American Jay Bhattacharya to be Trump's health agency head

Indian-American Jay Bhattacharya to be Trump's health agency head

Rediff.com27 Nov 2024

US President-elect Donald Trump has nominated Indian-American scientist Jay Bhattacharya to lead the National Institutes of Health (NIH), the country's top health research and funding institutions. Bhattacharya, a professor of Health Policy at Stanford University, is known for his research on the health and well-being of vulnerable populations. Trump also nominated Jim O'Neill as the deputy secretary of Health and Human Services to work alongside Robert F. Kennedy Jr.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Cloud over US FDA inspection

Cloud over US FDA inspection

Rediff.com19 Jul 2008

Two US Congress members have expressed doubts over the quality of inspections conducted by the US Food and Drugs Administration (FDA) on Indian drug manufacturing facilities.

Wockhardt gets import alert from US FDA

Wockhardt gets import alert from US FDA

Rediff.com6 Aug 2016

Ankleshwar plant is the third such facility to face action

Why US FDA is cracking down on India's shrimp shipments

Why US FDA is cracking down on India's shrimp shipments

Rediff.com12 Feb 2019

US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Pharma cos should learn to appreciate FDA norms: Experts

Pharma cos should learn to appreciate FDA norms: Experts

Rediff.com23 Nov 2014

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

US FDA India head quits; regulator goes for rejig

US FDA India head quits; regulator goes for rejig

Rediff.com21 Jul 2014

Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

Rediff.com17 Mar 2016

It is one of 42 drug-making factories in India that the FDA has banned in recent years

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Recipe: Walnut Chia Smoothie Pot

Recipe: Walnut Chia Smoothie Pot

Rediff.com11 Nov 2024

Start your day with walnuts, chia, fruit. You can't go wrong.

FDA halts sale of Bisleri!

FDA halts sale of Bisleri!

Rediff.com27 Oct 2004

The Maharashtra Food and Drug Administration has directed Parle Exports, manufacturers of Bisleri bottled water, not to release the product in the market till further orders.

Aurobindo gets FDA nod for drug

Aurobindo gets FDA nod for drug

Rediff.com27 Sep 2005

Aurobindo Pharma Ltd on Tuesday said it has received tentative approval from the US FDA for its Sertraline

FDA asks Wockhardt to conduct global assessment of its plants

FDA asks Wockhardt to conduct global assessment of its plants

Rediff.com4 Dec 2013

The FDA Commissioner Margaret Hamburg is slated to travel to India soon.

Standards violation: FDA seizes Caraco drugs

Standards violation: FDA seizes Caraco drugs

Rediff.com26 Jun 2009

The US Food and Drug Administration has seized drug products manufactured by Caraco Pharmaceutical, at the company's Michigan facilities in Detroit, Farmington Hills, and Wixom, the US FDA said on Thursday. The FDA seeks to immediately stop Caraco from further distributing drugs until there is assurance that the firm complies with good manufacturing requirements, it added.

No more Gobi Manchurian at north Goa's roadside food stalls

No more Gobi Manchurian at north Goa's roadside food stalls

Rediff.com6 Feb 2024

A civic body in North Goa has banned the sale of the popular street food 'Gobi Manchurian' at roadside stalls in its jurisdiction after concerns were raised about the unhygienic conditions in which the dish was prepared, an official said on Tuesday.

Baba Siddique: Political veteran known for grand Iftar parties

Baba Siddique: Political veteran known for grand Iftar parties

Rediff.com13 Oct 2024

Former Maharashtra minister Baba Siddique, who was shot dead in Mumbai, was a popular figure in Bollywood circles and had earned praise for supplying life-saving medicines to patients during the Covid pandemic.

Now, UP FDA finds lead in ITC's Yippee noodles

Now, UP FDA finds lead in ITC's Yippee noodles

Rediff.com24 Aug 2015

Uttar Pradesh Food and Drug Authority (FDA) says it has found excess lead in the Yippee noodles of domestic giant ITC.

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

Rediff.com20 Nov 2014

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Indian drug firms top FDA list

Indian drug firms top FDA list

Rediff.com17 Nov 2006

With 62 filings, domestic pharma companies have filed the maximum number of drug master filings with the US Food and Drug Administration in the July-September 2006 quarter.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Nestle India did not opt for re-test, instead burnt Maggi: FDA

Rediff.com29 Jul 2015

Maharashtra's Food and Drugs Administration on Wednesday argued in the Bombay High Court that Nestle India.

FDA warns Ranbaxy's American subsidiary

FDA warns Ranbaxy's American subsidiary

Rediff.com24 Dec 2009

The letter mentions certain cGMP violation based on site inspections conducted between July and August 2009.

US FDA to set up Indian offices by '09

US FDA to set up Indian offices by '09

Rediff.com21 Jul 2008

Under fire from some United States senators for allegedly taking lenient positions in granting product approvals to generic companies from countries like India, the US FDA is planning to speed up its plans to set up offices in India by 2009. FDA, in its latest newsletter dated July 21, has said that the agency will set up offices in Mumbai and Delhi to intensify its monitoring efforts.